Pictet Asset Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.2M | Sell |
1,474,449
-3,168
| -0.2% | -$99.2K | 0.05% | 327 |
|
|
2025
Q1 | $49.6M | Sell |
1,477,617
-18,894
| -1% | -$634K | 0.06% | 300 |
|
|
2024
Q4 | $58.7M | Sell |
1,496,511
-32,303
| -2% | -$1.27M | 0.06% | 270 |
|
|
2024
Q3 | $60.2M | Buy |
1,528,814
+49,323
| +3% | +$1.94M | 0.07% | 263 |
|
|
2024
Q2 | $57.7M | Sell |
1,479,491
-35,935
| -2% | -$1.4M | 0.07% | 257 |
|
|
2024
Q1 | $65.2M | Sell |
1,515,426
-524,974
| -26% | -$22.6M | 0.07% | 266 |
|
|
2023
Q4 | $94M | Buy |
2,040,400
+101,621
| +5% | +$4.68M | 0.1% | 212 |
|
|
2023
Q3 | $66.2M | Buy |
+1,938,779
| New | +$66.2M | 0.08% | 243 |
|